Respiratory Handbook
For UK audiences

The professional's guide to product selection

Products

Mometasone furoate - Sandoz Ltd
Sandoz

Mometasone furoate - Sandoz Ltd

Prophylaxis and treatment of allergic rhinitis by intranasal administration
• Child 3–11 years: 50 mcg daily, dose into each nostril.
• Over 12 years: 100 mcg daily, increased if necessary up to 200 mcg daily, dose into each nostril. Reduce to 50 mcg daily when controlled.

Management of nasal polyps by intranasal administration
• Adult: initially 100 mcg daily for five to six weeks, dose into each nostril, then increased if necessary to 100 mcg twice daily. Consider alternative if no improvement after five to six weeks. Reduce when controlled.

Mometasone furoate - Sigma Pharmaceuticals Plc
SIGMA Pharmaceuticals

Mometasone furoate - Sigma Pharmaceuticals Plc

Prophylaxis and treatment of allergic rhinitis by intranasal administration
• Child 3–11 years: 50 mcg daily, dose into each nostril.
• Over 12 years: 100 mcg daily, increased if necessary up to 200 mcg daily, dose into each nostril. Reduce to 50 mcg daily when controlled.

Management of nasal polyps by intranasal administration
• Adult: initially 100 mcg daily for five to six weeks, dose into each nostril, then increased if necessary to 100 mcg twice daily. Consider alternative if no improvement after five to six weeks. Reduce when controlled.

Mometasone furoate with glycopyrronium bromide and Indacaterol - Sandoz Ltd
Sandoz

Mometasone furoate with glycopyrronium bromide and Indacaterol - Sandoz Ltd

Long-acting selective beta2 agonist, long-acting muscarinic antagonist with corticosteroid.

Adult: one inhalation once daily.

Montelukast - AAH Pharmaceuticals
AAH Pharmaceuticals

Montelukast - AAH Pharmaceuticals

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening
• Adult and child over 15 years: 10 mg once daily in the evening

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening

Montelukast - Accord Healthcare
Accord Healthcare

Montelukast - Accord Healthcare

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Alliance Healthcare
Alliance Healthcare

Montelukast - Alliance Healthcare

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Almus Pharmaceuticals
Almus

Montelukast - Almus Pharmaceuticals

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Bristol Laboratories Ltd
Bristol Laboratories

Montelukast - Bristol Laboratories Ltd

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Consilient Health
Consilient Health

Montelukast - Consilient Health

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.

Montelukast - Crescent Pharma Ltd
Crescent Pharma

Montelukast - Crescent Pharma Ltd

A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.

Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.

Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.